Brisbane-based Altor Capital portfolio manager David McNamee specialises in investing in emerging companies with a market capitalisation under $200 million. … Read More
The post Altor Capital has high conviction on these 4 medtech plays for 2021 appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.